Tech Company Financing Transactions
Nuvelution Pharma Funding Round
Nuvelution Pharma closed a investment round on 7/14/2015. Investors included Clarus and Novo Ventures.
Transaction Overview
Company Name
Announced On
7/14/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Clarus (Nicholas Galakatos)
Novo Ventures (Thomas Dyrberg)
Proceeds Purpose
The initial investment will fund operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 Main St. 1210
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Our goal is to facilitate the advancement of late-stage clinical assets where R&D budget constraints have delayed further development by providing a R&D risk-sharing approach to financing as well as the human resources to get products with significant commercial potential to the market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanford Zweifach
Chief Financial Officer
Joe Poirier
VP - Bus. Development
James Cornwall
Browse more venture capital transactions:
Prev: 7/14/2015: Vapotherm venture capital transaction
Next: 7/14/2015: Realty Mogul venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs